Sesen Bio, Inc. has been dropped from NASDAQ Composite Index.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.465 USD | -1.01% | -8.41% | -50.14% |
May. 09 | Carisma Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 02 | Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.14% | 61.48M | |
+5.26% | 109B | |
+11.13% | 105B | |
-0.38% | 22.25B | |
-11.97% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.17% | 16.85B | |
+3.29% | 13.76B | |
+36.12% | 12.46B |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Sesen Bio, Inc.(NasdaqCM: SESN) dropped from NASDAQ Composite Index